Recommendations
| ShowHide Related Items >><< - $507.75 /
+22.075 (+4.55%) - 01/12/23
- VolitionRx: Nu.Q Vet Cancer Test available through Idexx Laboratories network
- $507.75 /
+22.075 (+4.55%) - 10/17/22 JPMorgan
- Idexx Laboratories price target lowered to $450 from $525 at JPMorgan
- 08/08/22 Piper Sandler
- Idexx Laboratories price target lowered to $420 from $500 at Piper Sandler
- 08/05/22 Barclays
- Idexx Laboratories price target lowered to $582 from $700 at Barclays
- 07/26/22 Piper Sandler
- Idexx Laboratories price target lowered to $420 from $440 at Piper Sandler
- $507.75 /
+22.075 (+4.55%) - 02/06/23
- Idexx Laboratories sees FY23 comparable EPS up 19%-26%, consensus $9.50
- 02/06/23
- Idexx Laboratories reports Q4 comparable EPS $2.07, consensus $1.94
- 11/01/22
- Idexx Laboratories cuts FY22 EPS view to $7.74-$7.98 from $8.11-$8.35
- 11/01/22
- Idexx Laboratories reports Q3 comparable EPS $2.23, consensus $2.04
- $507.75 /
+22.075 (+4.55%) - 02/06/23
- Fly Intel: Pre-market Movers
- $507.75 /
+22.075 (+4.55%) - 11/01/22
- Early notable gainers among liquid option names on November 1st
|
Recommendations
| ShowHide Related Items >><< - 01/19/23
- Desjardins selects Fiserv to enhance credit card program
- 12/21/22
- Fiserv enters into new contract with CEO Frank Bisignano
- 01/23/23 Barclays
- Fiserv price target lowered to $125 from $128 at Barclays
- 01/09/23 Wells Fargo
- Fiserv downgraded to Underweight from Equal Weight at Wells Fargo
- 12/12/22 Mizuho
- Fiserv price target lowered to $135 from $145 at Mizuho
- 10/28/22 Citi
- Fiserv price target lowered to $115 from $122 at Citi
- 02/07/23
- Fiserv sees FY23 adjusted EPS $7.25-$7.40, consensus $7.29
- 02/07/23
- Fiserv reports Q4 adjusted EPS $1.91, consensus $1.90
- 02/06/23
- Notable companies reporting before tomorrow's open
- 02/06/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- Fly Intel: Pre-market Movers
- 10/27/22
- Fly Intel: Pre-market Movers
- 10/12/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/11/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/07/23
- Early notable gainers among liquid option names on February 7th
- 12/14/22
- Early notable gainers among liquid option names on December 14th
- 10/10/22
- Fiserv call volume above normal and directionally bullish
- 08/22/22
- Fiserv put volume heavy and directionally bearish
|
Recommendations
| ShowHide Related Items >><< - 02/07/23
- Enphase Energy says plan to begin U.S. manufacturing of microinverters in Q2
- 02/07/23
- Enphase Energy CEO says January activations are holding up
- 02/07/23
- Enphase Energy jumps 11% to $253.91 after Q4 earnings beat
- 02/02/23
- Enphase Energy demonstrates bidirectional EV charger technology
- 02/03/23 Truist
- Enphase Energy price target lowered to $285 from $325 at Truist
- 02/03/23 Janney Montgomery Scott
- Enphase Energy initiated with a Neutral at Janney Montgomery Scott
- 02/01/23 Barclays
- SolarEdge price target lowered to $392 from $396 at Barclays
- 02/01/23 Barclays
- Enphase Energy price target lowered to $251 from $311 at Barclays
- 02/07/23
- Enphase Energy sees Q1 revenue $700M-$740M, consensus $690.46M
- 02/07/23
- Enphase Energy reports Q4 EPS $1.51, consensus $1.24
- 02/07/23
- Notable companies reporting after market close
- 10/25/22
- Enphase Energy sees Q4 revenue $680M-$720M, consensus $660.21M
- 02/07/23
- Fly Intel: After-Hours Movers
- 02/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/30/23
- What You Missed This Week in EVs and Clean Energy
- 12/27/22
- What You Missed This Week in EVs and Clean Energy
- 02/07/23
- Enphase Energy options imply 11.2% move in share price post-earnings
- 02/06/23
- Early notable gainers among liquid option names on February 6th
- 01/30/23
- Enphase Energy call volume above normal and directionally bullish
- 01/25/23
- Unusually active option classes on open January 25th
|
Recommendations
|
Barclays analyst Michael… ShowHide Related Items >><< - 02/07/23
- DuPont increases quarterly dividend 9% to 36c per share
- 11/14/22
- Third Point buys TJX, exits Cenovus Energy in Q3
- 11/10/22
- California AG sues DuPont, 3M over 'toxic forever chemicals'
- 11/08/22
- DuPont approves new $5B share buyback program, plans accelerated share buyback
- 01/17/23 Deutsche Bank
- DuPont downgraded to Hold from Buy at Deutsche Bank
- 01/12/23 KeyBanc
- DuPont downgraded to Sector Weight from Overweight at KeyBanc
- 12/20/22 JPMorgan
- DuPont reinstated with an Overweight at JPMorgan
- 12/15/22 Citi
- DuPont price target raised to $82 from $75 at Citi
- 02/07/23
- DuPont sees FY23 adjusted EPS $3.50-$4.00, consensus $3.84
- 02/07/23
- DuPont sees Q1 adjusted EPS 80c, consensus 89c
- 02/07/23
- DuPont reports Q4 adjusted EPS 89c, consensus 78c
- 11/08/22
- DuPont reports Q3 adjusted EPS 82c, consensus 79c
- 02/07/23
- What You Missed On Wall Street On Tuesday
- 02/07/23
- What You Missed On Wall Street This Morning
- 02/07/23
- Fly Intel: Pre-market Movers
- 11/08/22
- What You Missed On Wall Street On Tuesday
- 02/07/23
- Early notable gainers among liquid option names on February 7th
- 01/19/23
- DuPont de Nemours put volume heavy and directionally bearish
- 11/08/22
- Early notable gainers among liquid option names on November 8th
- 11/08/22
- Unusually active option classes on open November 8th
|
Recommendations
|
Barclays analyst Jeffrey… ShowHide Related Items >><< - $1,720.98 /
+22.435 (+1.32%) - 02/07/23
- Chipotle CEO: Feeling very good about where we are right now
- 02/07/23
- Chipotle sees Q1 comparable restaurant sales growth in high-single digits
- 02/07/23
- Chipotle reports Q4 operating margin 13.6%, up from 8.1% last year
- 01/26/23
- Chipotle launches new hiring campaign
- $1,720.98 /
+22.435 (+1.32%) - 01/23/23 Wells Fargo
- Chipotle initiated with an Overweight at Wells Fargo
- 01/17/23 Morgan Stanley
- Chipotle downgraded to Equal Weight from Overweight at Morgan Stanley
- 01/13/23 Evercore ISI
- Wendy's downgraded to In Line at Evercore, prefers share gainers
- 01/05/23 Barclays
- Chipotle price target lowered to $1,450 from $1,510 at Barclays
- $1,720.98 /
+22.435 (+1.32%) - 02/07/23
- Chipotle reports Q4 adjusted EPS $8.29, consensus $8.90
- 02/07/23
- Notable companies reporting after market close
- 10/25/22
- Chipotle reports Q3 adjusted EPS $9.51, consensus $9.21
- 10/25/22
- Notable companies reporting after market close
- $1,720.98 /
+22.435 (+1.32%) - 01/12/23
- Conagra doesn't see need for 'big' price hikes in 2023, WSJ says
- 01/11/23
- Subway looks into sale that could value company at over $10B, WSJ says
- 12/30/22
- Restaurant coalition sues to stop California fast-food wage law, WSJ says
- 12/01/22
- Twitter offers advertisers big incentives to boost spending, WSJ reports
- $1,720.98 /
+22.435 (+1.32%) - 02/07/23
- Fly Intel: After-Hours Movers
- 01/24/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/17/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/07/22
- #SocialStocks: EU rules against Meta, despite attempts to settle
- $1,720.98 /
+22.435 (+1.32%) - 02/07/23
- Chipotle options imply 5.5% move in share price post-earnings
- 10/25/22
- Chipotle options imply 6.3% move in share price post-earnings
|
Earnings
| ShowHide Related Items >><< - 02/01/23
- Euronet's platform to enhance prepaid card issuing services for SOLFIN
- 12/15/22
- Euronet launches refreshed brand strategy, new logo, mission statement
- 12/13/22
- Euronet announces Ren Payments Platform selected by BNC
- 12/08/22
- Euronet appoints Torres to board of directors
- 01/23/23 Citi
- Euronet downgraded to Neutral from Buy at Citi
- 01/20/23 Truist
- Euronet price target raised to $135 from $100 at Truist
- 01/12/23 DA Davidson
- DA Davidson expects material FX headwinds for Euronet to diminish
- 01/05/23 Wolfe Research
- Euronet downgraded to Underperform from Peer Perform at Wolfe Research
|
Recommendations
| ShowHide Related Items >><< - 02/02/23
- Managed care stocks pressured after CMS' preliminary Medicare Advantage rates
- 01/23/23
- Centene completes divestiture of Magellan Specialty Health to Evolent Health
- 01/03/23
- Centene's Health Net selected for new medi-cal direct contracts
- 12/16/22
- Centene announces $2B increase to stock repurchase program
- 01/31/23 JPMorgan
- Medicare Advantage final rule more favorable than feared, says JPMorgan
- 12/23/22 Wells Fargo
- Humana keeps TRICARE East, Centene loses West region, says Wells Fargo
- 12/23/22 Credit Suisse
- TRICARE contract a win for Humana, loss for Centene, says Credit Suisse
- 12/14/22 Argus
- Centene price target raised to $99 from $95 at Argus
- 02/07/23
- Centene backs FY23 adjusted EPS view $6.25-$6.40, consensus $6.36
- 02/07/23
- Centene reports Q4 EPS 86c, consensus 85c
- 02/06/23
- Notable companies reporting before tomorrow's open
- 02/06/23
- Notable companies reporting before tomorrow's open
- 11/29/22
- Managed care company returns will be tough to keep replicating, WSJ says
- 09/23/22
- Nebraska picks two current, one new Medicaid health plan provider, OWH reports
- 09/23/22
- UnitedHealth, Molina, Centene win Medicaid contracts in Nebraska, Bloomberg says
- 08/18/22
- White House plans for end of COVID-19 vaccine coverage, WSJ reports
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 01/03/23
- What You Missed On Wall Street This Morning
- 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- What You Missed On Wall Street This Morning
- 01/17/23
- Centene call volume above normal and directionally bullish
- 01/09/23
- Centene put volume heavy and directionally bearish
- 12/22/22
- Early notable gainers among liquid option names on December 22nd
- 11/21/22
- Centene put volume heavy and directionally bearish
|
Recommendations
| ShowHide Related Items >><< - 02/06/23
- Catalent rises 20.2%
- 02/06/23
- Catalent rises 23.0%
- 02/06/23
- Catalent rises 23.7%
- 02/05/23
- Fly Intel: Top five weekend stock stories
- 02/06/23 Jefferies
- Jefferies says Catalent could be valued near $93 on average CDMO buyout multiple
- 02/06/23 BofA
- Premium required for any Catalent-Danaher deal 'up for debate,' says BofA
- 01/24/23 Barclays
- Catalent price target lowered to $58 from $62 at Barclays
- 12/19/22 KeyBanc
- Catalent downgraded to Sector Weight from Overweight at KeyBanc
- 02/07/23
- Catalent sees FY23 revenue $4.63B-$4.88B, consensus $4.69B
- 02/07/23
- Catalent reports Q2 adjusted EPS 67c, consensus 69c
- 11/01/22
- Catalent cuts FY23 revenue view to $4.625B-$4.875B from $4.975B-$5.225B
- 11/01/22
- Catalent reports Q1 adjusted EPS 34c, consensus 56c
- 02/04/23
- Danaher has expressed takeover interest in Catalent, Bloomberg says
- 01/13/23
- Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports
- 12/08/22
- Glasshouse Research short Catalent, cites 'accounting red flags'
- 08/11/22
- Repligen turned down bid from Catalent, Street Insider says
- 02/06/23
- What You Missed On Wall Street On Monday
- 02/06/23
- What You Missed On Wall Street This Morning
- 02/06/23
- Fly Intel: Pre-market Movers
- 12/08/22
- What You Missed On Wall Street On Thursday
- 02/06/23
- Early notable gainers among liquid option names on February 6th
- 01/11/23
- Early notable gainers among liquid option names on January 11th
- 12/09/22
- Early notable gainers among liquid option names on December 9th
|
Recommendations
| ShowHide Related Items >><< - 02/06/23
- Carrier Global strengthens climate goals
- 12/07/22
- Carrier Global raises quarterly dividend 23% to 18.5c per share
- 10/27/22
- Carrier Global approves $2B share repurchase authorization
- 09/14/22
- Carrier Ventures invests in next-generation sustainable technology startups
- 01/26/23 OTR Global
- U.S. commercial HVAC equipment view upgraded at OTR Global
- 01/13/23 Mizuho
- Carrier Global upgraded to Buy from Neutral at Mizuho
- 12/13/22 KeyBanc
- Carrier Global downgraded to Sector Weight from Overweight at KeyBanc
- 12/09/22 Citi
- Carrier Global price target raised to $45 from $39 at Citi
- 02/07/23
- Carrier Global sees FY23 adjusted EPS $2.50-$2.60, consensus $2.56
- 02/07/23
- Carrier Global reports Q4 adjusted EPS 40c, consensus 40c
- 10/27/22
- Carrier Global narrows FY22 adjusted EPS view to $2.30-$2.35 from $2.25-$2.35
- 10/27/22
- Carrier Global reports Q3 adjusted EPS 70c, consensus 65c
|
Recommendations
| ShowHide Related Items >><< - 10/03/22 Barclays
- Kennametal price target lowered to $24 from $25 at Barclays
- 08/03/22 Barclays
- Kennametal price target lowered to $25 from $26 at Barclays
- 07/20/22 Loop Capital
- Kennametal price target lowered to $22 from $29 at Loop Capital
- 07/15/22 Jefferies
- Kennametal price target lowered to $35 from $45 at Jefferies
- 02/06/23
- Kennametal reaffirms FY23 adjusted EPS view $1.30-$1.70, consensus $1.47
- 02/06/23
- Kennametal sees Q3 revenue $520M-$540M, consensus $510.46M
- 02/06/23
- Kennametal reports Q2 EPS 27c, consensus 22c
- 10/31/22
- Kennametal sees FY23 adjusted EPS $1.30-$1.70, consensus $1.73
- 02/06/23
- Fly Intel: After-Hours Movers
|